NCT04920695View on ClinicalTrials.gov

Inhaled Nitric Oxide (iNO) in Post-Pulmonary Embolism (Post-PE)

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 14, 2021

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions
DyspneaPulmonary Embolism
Interventions
DRUG

Nitric Oxide

Pulmonary vasodilator (gas).

DRUG

Placebo

medical grade normoxic gas (FiO2 = 0.21)

Trial Locations (1)

K7L 2V7

Respiratory Investigation Unit, Kingston General Hospital, Kingston

All Listed Sponsors
lead

Dr. Denis O'Donnell

OTHER